|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with PDL1 x CD3ε x CD47
100 Translational Medicine associated with PDL1 x CD3ε x CD47
0 Patents (Medical) associated with PDL1 x CD3ε x CD47